Symbols / RDHL $0.80 -1.68% RedHill Biopharma Ltd.

Healthcare • Drug Manufacturers - Specialty & Generic • Israel • NCM
RDHL Chart
About

RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company develops and commercializes Talicia for the treatment of H. pylori infection in adults; and Aemcolo for the treatment of travelers' diarrhea in adults. Its pipeline consists of five therapeutic candidates, which are in clinical development include opaganib for treating patients hospitalized with SARS-CoV-2 severe COVID-19 pneumonia, prostate cancer, nuclear radiation protection; and host directed anti-viral; RHB-107 (upamostat) for treating outpatients infected with SARS-CoV-2 (COVID-19 disease) and advanced unresectable cholangiocarcinoma; RHB-104 for Crohn's disease; RHB-102 (Bekinda) for the treatment of acute gastroenteritis and gastritis, irritable bowel syndrome with diarrhea, and oncology support anti-emetic; and RHB-204 that is in Phase 3 clinical trial for the treatment of pulmonary Mycobacterium avium complex disease in adults. The company was incorporated in 2009 and is headquartered in Tel Aviv-Yafo, Israel.

Fundamentals
Scroll to Statements
Sector Healthcare Industry Drug Manufacturers - Spe Market Cap 4.09M
Enterprise Value 14.41B Income -9.31M Sales 9.55M
Book/sh -2.45 Cash/sh 2866000.00 Dividend Yield —
Payout 0.00% Employees 35 IPO —
P/E inf Forward P/E 26.65 PEG —
P/S 0.43 P/B -0.33 P/C —
EV/EBITDA -1728.71 EV/Sales 1508.96 Quick Ratio 0.37
Current Ratio 0.56 Debt/Eq — LT Debt/Eq —
EPS (ttm) 0.00 EPS next Y 0.03 EPS Growth —
Revenue Growth 58.60% Earnings 2023-04-28 07:00 ROA -25.32%
ROE — ROIC — Gross Margin 64.45%
Oper. Margin -107.33% Profit Margin -97.52% Shs Outstand 5.11M
Shs Float 15.09B Short Float 0.40% Short Ratio 0.44
Short Interest — 52W High 3.31 52W Low 0.71
Beta 4.92 Avg Volume 56.02K Volume 12.91K
Target Price — Recom None Prev Close $0.81
Price $0.80 Change -1.68%
Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
—
Mean price target
2. Current target
$0.80
Latest analyst target
3. DCF / Fair value
$-14.36
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$0.80
Low
—
High
—
Mean
—
News
RSS: Latest RDHL news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Revenue
8.04
+23.17%
6.53
-89.43%
61.80
-27.94%
85.76
Operating Revenue
8.04
+23.17%
6.53
-89.43%
61.80
-27.94%
85.76
Cost Of Revenue
3.19
-7.72%
3.46
-89.62%
33.34
-32.52%
49.41
Reconciled Cost Of Revenue
3.19
-7.72%
3.46
-89.62%
33.34
-32.52%
49.41
Gross Profit
4.85
+57.96%
3.07
-89.21%
28.46
-21.70%
36.35
Operating Expense
17.11
-50.42%
34.50
-51.61%
71.31
-39.31%
117.49
Research And Development
1.59
-54.99%
3.53
-51.53%
7.28
-75.32%
29.50
Selling General And Administration
15.52
-49.90%
30.98
-51.62%
64.03
-27.23%
87.99
Selling And Marketing Expense
1.00
-52.17%
2.10
-76.87%
9.06
-20.44%
11.38
General And Administrative Expense
14.52
-49.74%
28.88
-47.46%
54.97
-28.24%
76.60
Salaries And Wages
8.10
-55.49%
18.20
-46.91%
34.28
-22.97%
44.50
Other Gand A
6.42
-39.93%
10.68
-48.38%
20.69
-35.55%
32.10
Other Operating Expenses
—
-44.06
—
—
Total Expenses
20.30
-46.53%
37.96
-63.72%
104.64
-37.30%
166.89
Operating Income
-12.25
+61.01%
-31.43
+26.64%
-42.84
+47.19%
-81.14
Total Operating Income As Reported
-14.61
-215.68%
12.63
+129.48%
-42.84
+47.19%
-81.14
EBITDA
-7.59
-128.90%
26.27
+218.44%
-22.18
+64.81%
-63.03
Normalized EBITDA
-13.43
+40.75%
-22.67
+36.26%
-35.56
+43.55%
-63.00
Reconciled Depreciation
0.62
-68.89%
1.99
-75.59%
8.15
-55.07%
18.15
EBIT
-8.21
-133.82%
24.28
+180.05%
-30.34
+62.63%
-81.18
Total Unusual Items
5.84
-88.07%
48.94
+265.73%
13.38
+47892.86%
-0.03
Total Unusual Items Excluding Goodwill
5.84
-88.07%
48.94
+265.73%
13.38
+47892.86%
-0.03
Special Income Charges
-2.36
-104.32%
54.63
0.00
0.00
Other Special Charges
2.36
+112.33%
-19.13
—
—
Net Income
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Pretax Income
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Net Non Operating Interest Income Expense
-1.85
+14.18%
-2.16
+94.89%
-42.21
-154.55%
-16.58
Interest Expense Non Operating
0.06
-85.01%
0.37
-99.11%
41.33
+149.49%
16.57
Net Interest Income
-1.85
+14.18%
-2.16
+94.89%
-42.21
-154.55%
-16.58
Interest Expense
0.06
-85.01%
0.37
-99.11%
41.33
+149.49%
16.57
Interest Income Non Operating
0.13
+41.49%
0.09
-32.86%
0.14
+174.51%
0.05
Interest Income
0.13
+41.49%
0.09
-32.86%
0.14
+174.51%
0.05
Other Income Expense
5.84
-89.85%
57.51
+329.73%
13.38
+47892.86%
-0.03
Other Non Operating Income Expenses
—
8.56
—
—
Gain On Sale Of Security
8.20
+244.21%
-5.68
-142.47%
13.38
+47892.86%
-0.03
Gain On Sale Of Business
—
35.50
—
—
Tax Rate For Calcs
0.00
-100.00%
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
-100.00%
11.26
0.00
0.00
Net Income Including Noncontrolling Interests
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Net Income From Continuing Operation Net Minority Interest
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Net Income From Continuing And Discontinued Operation
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Net Income Continuous Operations
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Normalized Income
-14.11
-2.44%
-13.77
+83.81%
-85.05
+12.96%
-97.72
Net Income Common Stockholders
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Diluted EPS
0.00
-100.00%
100.00
+108.33%
-1,200.00
+42.86%
-2,100.00
Basic EPS
0.00
-100.00%
100.00
+108.33%
-1,200.00
+42.86%
-2,100.00
Basic Average Shares
1.29
+397.83%
0.26
+320.45%
0.06
+32.46%
0.05
Diluted Average Shares
1.29
+397.83%
0.26
+320.45%
0.06
+32.46%
0.05
Diluted NI Availto Com Stockholders
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Total Other Finance Cost
1.93
+2.39%
1.89
+85.90%
1.01
+1460.00%
0.07
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total Assets
18.04
-21.71%
23.05
-85.49%
158.87
-12.32%
181.19
Current Assets
11.91
-26.20%
16.14
-81.21%
85.90
-3.65%
89.15
Cash Cash Equivalents And Short Term Investments
4.62
-17.09%
5.57
-72.13%
19.98
-47.42%
38.00
Cash And Cash Equivalents
4.62
-17.09%
5.57
-72.11%
19.97
-32.25%
29.47
Cash Equivalents
2.73
0.00
-100.00%
6.64
+1037.84%
0.58
Cash Financial
1.88
-66.21%
5.57
-58.20%
13.32
-53.88%
28.89
Other Short Term Investments
—
0.00
-100.00%
0.01
-99.82%
8.53
Receivables
3.57
-12.64%
4.08
-89.22%
37.88
+16.45%
32.52
Accounts Receivable
2.54
-2.01%
2.59
-92.49%
34.52
+8.98%
31.68
Other Receivables
1.03
-31.12%
1.49
-55.55%
3.35
+295.99%
0.85
Inventory
3.65
-16.81%
4.39
-60.13%
11.01
-25.67%
14.81
Raw Materials
0.51
-38.04%
0.83
-53.92%
1.80
-40.34%
3.01
Work In Process
0.31
+32.19%
0.23
-90.23%
2.38
-54.09%
5.20
Finished Goods
2.83
-14.96%
3.33
-51.25%
6.83
+3.39%
6.60
Prepaid Assets
0.08
-94.12%
1.31
+26.82%
1.03
-72.92%
3.81
Restricted Cash
0.00
-100.00%
0.79
-95.06%
16.00
0.00
Total Non Current Assets
6.13
-11.22%
6.91
-90.53%
72.97
-20.72%
92.04
Net PPE
0.44
-63.03%
1.18
-83.57%
7.19
+70.35%
4.22
Gross PPE
1.75
-27.94%
2.43
-70.65%
8.27
+64.35%
5.03
Accumulated Depreciation
-1.31
-5.38%
-1.25
-15.71%
-1.08
-33.00%
-0.81
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
1.07
-16.24%
1.27
-43.61%
2.26
-15.92%
2.69
Other Properties
—
—
5.63
+183.48%
1.99
Leases
0.68
-40.89%
1.15
-80.83%
6.01
+156.47%
2.34
Goodwill And Other Intangible Assets
5.55
-0.56%
5.58
-91.50%
65.63
-8.40%
71.64
Other Intangible Assets
5.55
-0.56%
5.58
-91.50%
65.63
-8.40%
71.64
Other Non Current Assets
0.15
+0.68%
0.15
-2.00%
0.15
-99.07%
16.17
Total Liabilities Net Minority Interest
22.73
+8.33%
20.98
-89.88%
207.27
+20.29%
172.31
Current Liabilities
22.22
+11.21%
19.98
-89.88%
197.45
+142.36%
81.47
Payables And Accrued Expenses
10.56
+49.92%
7.04
-77.68%
31.55
-30.61%
45.48
Payables
7.86
+139.81%
3.28
-78.70%
15.39
-45.52%
28.25
Accounts Payable
7.86
+139.81%
3.28
-22.51%
4.23
-63.73%
11.66
Other Payable
—
—
11.16
-32.71%
16.58
Current Accrued Expenses
2.70
-28.34%
3.77
-76.71%
16.17
-6.18%
17.23
Pensionand Other Post Retirement Benefit Plans Current
0.51
-29.85%
0.73
-56.39%
1.67
-52.32%
3.50
Current Debt And Capital Lease Obligation
0.35
-50.84%
0.72
-99.38%
116.25
+7084.67%
1.62
Current Debt
—
—
115.22
—
Other Current Borrowings
—
—
115.22
—
Current Capital Lease Obligation
0.35
-50.84%
0.72
-30.43%
1.03
-36.22%
1.62
Other Current Liabilities
1.51
+79.90%
0.84
+637.72%
0.11
-31.74%
0.17
Total Non Current Liabilities Net Minority Interest
0.50
-49.45%
0.99
-89.86%
9.82
-89.19%
90.84
Long Term Debt And Capital Lease Obligation
0.00
-99.34%
0.46
-92.94%
6.44
-92.53%
86.19
Long Term Debt
—
—
—
83.62
Long Term Capital Lease Obligation
0.00
-99.34%
0.46
-92.94%
6.44
+150.31%
2.57
Tradeand Other Payables Non Current
—
—
0.00
-100.00%
3.90
Other Non Current Liabilities
0.50
-7.41%
0.54
-28.00%
0.75
+0.00%
0.75
Stockholders Equity
-4.68
-326.34%
2.07
+104.27%
-48.40
-645.35%
8.88
Common Stock Equity
-4.68
-326.34%
2.07
+104.27%
-48.40
-645.35%
8.88
Capital Stock
35.04
+63.41%
21.44
+656.30%
2.83
+89.63%
1.50
Common Stock
35.04
+63.41%
21.44
+656.30%
2.83
+89.63%
1.50
Share Issued
12,899.83
+63.91%
7,869.85
+744.44%
931.96
+77.85%
524.02
Ordinary Shares Number
12,899.83
+63.91%
7,869.85
+744.44%
931.96
+77.85%
524.02
Additional Paid In Capital
375.08
-3.42%
388.36
+1.50%
382.62
+1.97%
375.25
Retained Earnings
-414.80
-1.73%
-407.74
+6.02%
-433.86
-17.94%
-367.87
Total Equity Gross Minority Interest
-4.68
-326.34%
2.07
+104.27%
-48.40
-645.35%
8.88
Total Capitalization
-4.68
-326.34%
2.07
+104.27%
-48.40
-152.33%
92.50
Working Capital
-10.31
-168.33%
-3.84
+96.56%
-111.55
-1552.15%
7.68
Invested Capital
-4.68
-326.34%
2.07
-96.90%
66.82
-27.76%
92.50
Total Debt
0.36
-69.65%
1.17
-99.04%
122.69
+39.72%
87.81
Net Debt
—
—
95.25
+75.91%
54.15
Capital Lease Obligations
0.36
-69.65%
1.17
-84.31%
7.47
+78.32%
4.19
Net Tangible Assets
-10.23
-191.54%
-3.51
+96.92%
-114.03
-81.66%
-62.77
Tangible Book Value
-10.23
-191.54%
-3.51
+96.92%
-114.03
-81.66%
-62.77
Current Provisions
9.29
-12.82%
10.65
-77.74%
47.87
+55.87%
30.71
Derivative Product Liabilities
—
0.74
-71.75%
2.62
0.00
Line Item Trend 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Operating Cash Flow
-9.37
+73.84%
-35.82
-22.73%
-29.18
+55.13%
-65.05
Cash Flow From Continuing Operating Activities
-9.37
+73.84%
-35.82
-22.73%
-29.18
+55.13%
-65.05
Net Income From Continuing Operations
-8.27
-134.57%
23.92
+133.37%
-71.67
+26.68%
-97.74
Depreciation Amortization Depletion
0.62
-68.89%
1.99
-75.59%
8.15
-55.07%
18.15
Depreciation
0.59
-59.31%
1.45
-32.35%
2.14
+11.60%
1.91
Amortization Cash Flow
0.03
-94.31%
0.55
-90.94%
6.02
-62.93%
16.23
Depreciation And Amortization
0.62
-68.89%
1.99
-75.59%
8.15
-55.07%
18.15
Amortization Of Intangibles
0.03
-94.31%
0.55
-90.94%
6.02
-62.93%
16.23
Other Non Cash Items
2.34
+530.39%
-0.54
-101.64%
33.15
+517.80%
5.37
Stock Based Compensation
0.67
-59.62%
1.65
-70.98%
5.67
-44.43%
10.21
Operating Gains Losses
-6.78
+85.65%
-47.21
-277.57%
-12.50
-10265.85%
0.12
Gain Loss On Investment Securities
-6.77
-176.49%
8.85
+171.02%
-12.46
-249380.00%
0.01
Unrealized Gain Loss On Investment Securities
—
—
0.00
-100.00%
0.01
Net Foreign Currency Exchange Gain Loss
-0.00
-121.05%
0.02
+147.50%
-0.04
-133.90%
0.12
Change In Working Capital
2.05
+113.14%
-15.62
-295.04%
8.01
+794.54%
-1.15
Change In Receivables
0.05
-99.84%
31.93
+1222.32%
-2.85
+5.83%
-3.02
Changes In Account Receivables
0.05
-99.84%
31.93
+1222.32%
-2.85
+5.83%
-3.02
Change In Inventory
0.74
-69.08%
2.39
-37.20%
3.80
+145.88%
-8.29
Change In Prepaid Assets
1.70
+7.00%
1.59
+478.83%
0.27
-68.14%
0.86
Change In Payables And Accrued Expense
0.93
+106.51%
-14.31
-37.81%
-10.38
-237.59%
-3.08
Change In Accrued Expense
3.04
+122.78%
-13.35
-353.14%
-2.95
+7.50%
-3.19
Change In Payable
-2.11
-121.64%
-0.95
+87.19%
-7.43
-6797.30%
0.11
Change In Account Payable
-2.11
-121.64%
-0.95
+87.19%
-7.43
-6797.30%
0.11
Change In Other Working Capital
-1.37
+96.33%
-37.22
-316.89%
17.16
+38.74%
12.37
Investing Cash Flow
-0.01
-325.00%
0.00
-99.95%
8.30
+201.99%
-8.14
Cash Flow From Continuing Investing Activities
-0.01
-325.00%
0.00
-99.95%
8.30
+201.99%
-8.14
Net PPE Purchase And Sale
-0.01
+18.18%
-0.01
+94.44%
-0.20
-72.17%
-0.12
Purchase Of PPE
-0.01
+18.18%
-0.01
+94.44%
-0.20
-72.17%
-0.12
Capital Expenditure
-0.01
+18.18%
-0.01
+94.44%
-0.20
-72.17%
-0.12
Net Investment Purchase And Sale
0.00
-100.00%
0.01
-99.82%
8.50
+205.92%
-8.03
Purchase Of Investment
—
—
—
-8.50
Sale Of Investment
—
0.01
-99.82%
8.50
+1689.47%
0.47
Gain Loss On Sale Of Business
0.00
+100.00%
-56.08
0.00
0.00
Net Intangibles Purchase And Sale
—
—
0.00
0.00
Purchase Of Intangibles
—
—
0.00
0.00
Financing Cash Flow
8.42
-60.74%
21.44
+87.19%
11.45
-84.41%
73.46
Cash Flow From Continuing Financing Activities
8.42
-60.74%
21.44
+87.19%
11.45
-84.41%
73.46
Net Issuance Payments Of Debt
-0.64
+45.87%
-1.18
+20.34%
-1.48
+12.36%
-1.68
Issuance Of Debt
—
—
0.00
0.00
Repayment Of Debt
-0.64
+45.87%
-1.18
+20.34%
-1.48
+12.36%
-1.68
Long Term Debt Issuance
—
—
0.00
0.00
Long Term Debt Payments
-0.64
+45.87%
-1.18
+20.34%
-1.48
+12.36%
-1.68
Net Long Term Debt Issuance
-0.64
+45.87%
-1.18
+20.34%
-1.48
+12.36%
-1.68
Net Common Stock Issuance
8.26
-40.81%
13.96
-41.36%
23.81
-69.69%
78.54
Proceeds From Stock Option Exercised
—
0.00
0.00
-100.00%
4.01
Net Other Financing Charges
0.79
-90.87%
8.65
+179.56%
-10.88
-47.06%
-7.40
Changes In Cash
-0.96
+93.32%
-14.38
-52.46%
-9.43
-3529.09%
0.28
Effect Of Exchange Rate Changes
0.01
+140.91%
-0.02
+71.05%
-0.08
+20.83%
-0.10
Beginning Cash Position
5.57
-72.11%
19.97
-32.25%
29.47
+0.61%
29.30
End Cash Position
4.62
-17.09%
5.57
-72.11%
19.97
-32.25%
29.47
Free Cash Flow
-9.38
+73.83%
-35.83
-21.94%
-29.38
+54.91%
-65.16
Interest Paid Supplemental Data
0.06
-85.01%
0.37
-95.51%
8.18
-27.46%
11.28
Common Stock Issuance
8.26
-40.81%
13.96
-41.36%
23.81
-69.69%
78.54
Issuance Of Capital Stock
8.26
-40.81%
13.96
-41.36%
23.81
-69.69%
78.54
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category